PAA 0.00% 19.5¢ pharmaust limited

Ann: Appendix 4C and Quarterly Update, page-140

  1. 642 Posts.
    lightbulb Created with Sketch. 111
    Elanco didn’t give anything away on their earnings call. ‘More to come’ on Companion Animal product launches. But the Bayer acquisition has definitely slowed down a possible take up of the MPL option. Elanco has to check Bayer’s pipeline. Did Bayer ever have a competitor to MPL?

    I think it will be the end of the 6 months when we find out.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.